Aureus Pharma appoints Jason Theodosiou as new CEO
Past CEO André Michel appointed Chairman of the Supervisory Board
Aureus Pharma announced changes in Aureus´s Executive and Supervisory Boards. Jason Theodosiou has been appointed Chief Executive Officer (CEO). Theodosiou will replace André Michel, founder of Aureus who has been appointed to Chairman of the Supervisory Board. These changes will become effective immediately.
Mr. Theodosiou was previously Chief Operating Officer of Aureus. Prior to Aureus, he held various executive management positions at various companies including Elsevier MDL, Lion Bioscience, and EMAX/SciQuest.
André Michel, founder and CEO of the company since 2000, was previously Professor of Chemistry at Sherbrooke University (Canada) and Director of the Discovery Centers at Servier.
Most read news
Other news from the department people

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.